Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| QXO, Inc.(QXO) | 0 | 25,750,781 | +25,750,781 | $0 | $406.09M | 49.38% | +$406.09M |
| Liberty Broadband CorpCOM SER C | 1,994,510 | 1,994,510 | 0 | $109.34M | $154.16M | 18.75% | +$44.82M |
| Revolution Medicines, Inc.(RVMD) | 729,464 | 731,960 | +2,496 | $28.31M | $33.19M | 4.04% | +$4.88M |
| argenx SEADR(ARGX) | 54,028 | 54,428 | +400 | $23.23M | $29.50M | 3.59% | +$6.27M |
| Ascendis Pharma A/SADR(ASND) | 189,272 | 190,072 | +800 | $25.81M | $28.38M | 3.45% | +$2.57M |
| Travere Therapeutics, Inc.(TVTX) | 1,776,728 | 1,782,267 | +5,539 | $14.60M | $24.93M | 3.03% | +$10.33M |
| Springworks Therapeutics Inc | 638,352 | 650,852 | +12,500 | $24.05M | $20.85M | 2.54% | -$3.19M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 388,835 | 388,835 | 0 | $17.10M | $19.61M | 2.38% | +$2.51M |
| Sarepta Therapeutics, Inc.(SRPT) | 132,835 | 133,535 | +700 | $20.99M | $16.68M | 2.03% | -$4.31M |
| Lakefront Biotherapeutics NVADR(LKFT) | 542,762 | 557,762 | +15,000 | $13.45M | $16.06M | 1.95% | +$2.61M |
| Arvinas, Inc.(ARVN) | 574,378 | 574,378 | 0 | $15.29M | $14.15M | 1.72% | -$1.14M |
| Acadia Pharmaceuticals Inc | 905,384 | 905,384 | 0 | $14.71M | $13.92M | 1.69% | -$787.7K |
| Cytokinetics, Incorporated(CYTK) | 256,449 | 256,449 | 0 | $13.89M | $13.54M | 1.65% | -$353.9K |
| Relay Therapeutics, Inc.(RLAY) | 1,605,346 | 1,626,146 | +20,800 | $10.47M | $11.51M | 1.40% | +$1.05M |
| Prothena Corp PlcSHS SHS | 433,471 | 433,471 | 0 | $8.95M | $7.25M | 0.88% | -$1.69M |
| Solid Biosciences Inc | 961,251 | 961,251 | 0 | $5.45M | $6.70M | 0.81% | +$1.25M |
| EyePoint, Inc.(EYPT) | 707,404 | 707,404 | 0 | $6.15M | $5.65M | 0.69% | -$502.3K |
| Swiftmerge Acquisition CorpW EXP 12 13 202 | 490,000 | 490,000 | 0 | $39.2K | $39.2K | 0.00% | $0 |
| Compass Digital Acquisition CorpW EXP 09 29 202 | 459,906 | 459,906 | 0 | $27.5K | $28.1K | 0.00% | +$506 |
| Moneyhero LimitedW EXP 09 13 202 *W EXP 09/13/202 | 895,000 | 895,000 | 0 | $71.6K | $26.9K | 0.00% | -$44.8K |
| Marblegate Acquisition CorpW EXP 08 31 202 | 735,000 | 735,000 | 0 | $26.8K | $25.3K | 0.00% | -$1.5K |
| Lakeshore Biopharma Co LtdW EXP 03 15 202 | 489,999 | 489,999 | 0 | $33.4K | $24.2K | 0.00% | -$9.2K |
| Calidi Biotherapeutics Inc | 0 | 12,500 | +12,500 | $0 | $14.2K | 0.00% | +$14.2K |
| Calidi Biotherapeutics IncW EXP 03 14 202 | 655,200 | 655,200 | 0 | $27.6K | $8.6K | 0.00% | -$19.0K |
| Calidi Biotherapeutics Inc | 125,000 | 0 | -125,000 | $25.0K | $0 | — | -$25.0K |
| Churchill Capital Corp ViiW EXP 02 29 202 | 548,000 | 0 | -548,000 | $191.8K | $0 | — | -$191.8K |
| Concord Acquisition Corp IIW EXP 99 99 999(CNDA) | 408,333 | 0 | -408,333 | $44.9K | $0 | — | -$44.9K |